Resulting from a development project between SGD Pharma Quality and Marketing departments, this digital tool makes it possible to identify non-compliances that may be discovered during an incoming inspection or during an on-line inspection at the client´s side. The SGD Pharma App demonstrates transparency in working with customers toward the mutual objective of safeguarding patient health. As a leader in molded glass pharmaceutical packaging for the healthcare sector, SGD Pharma makes product quality an essential part of its mission. The app aims at optimizing and harmonizing exchanges with quality controllers and technical staff by making it easier to identify non-compliances that could be present in molded glass bottles intended for pharmaceutical use.
Available for free from the Apple Store and the Play Store, it only takes a few clicks for users to create their account and have unlimited access to a 2D visual compilation of the most frequently encountered forms of non-compliance. Users can refine their searches by administration method (parenteral, oral or nasal), by location or non-compliance types corresponding to various effects on the patients or on filling lines (critical, major or cosmetic). Once a non-compliance has been identified, the user then accesses a dedicated page including a visual, a definition, the type of non-compliance and its associated acceptable quality level (AQL) in conjunction with the international standard ISO 2859-1. As an added benefit, the SGD Pharma standards are then cross-referenced with the two quality benchmarks recognized and accepted by the Pharmaceutical industry: technical report 43 from the Parenteral Drug Association (PDA) and the list of molded glass container non-compliances from Edito-Cantor-Verlag (ECV).
